To further explore whether PPARγ was directly involved in VEGF transcription in MM cells in a previous study (Fang et al., 2016), we used the PPARγ ligand agonist RSG and antagonist GW9662 to detect its effect on transcriptional activation (Schubert et al., 2020; Fu et al., 2021). This evidence concerns the gene PPARG and Miyoshi myopathy.